Academic

The New York Times has an interesting article on ghost writing in medical academia - here’s the lead in:

The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article to be published Wednesday in a leading medical journal.  The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals.

Read more from the NYT story here. The JAMA article can be found here. Hat tip to Science & Law Blog.